BTG plc Earns Buy Rating from Deutsche Bank (BTG)
BTG plc (LON:BTG) traded up 3.33% on Tuesday, hitting GBX 652.00. The stock had a trading volume of 293,073 shares. BTG plc has a one year low of GBX 363.00 and a one year high of GBX 665.00. The stock’s 50-day moving average is GBX 614.4 and its 200-day moving average is GBX 585.. The company’s market cap is £2.353 billion.
A number of other analysts have also recently weighed in on BTG. Analysts at Jefferies Group upgraded shares of BTG plc to a “buy” rating in a research note on Tuesday, July 29th. They now have a GBX 760 ($12.58) price target on the stock, up previously from GBX 525 ($8.69). Separately, analysts at N+1 Singer reiterated a “sell” rating on shares of BTG plc in a research note on Wednesday, July 16th. They now have a GBX 486 ($8.04) price target on the stock. Finally, analysts at Panmure Gordon reiterated a “buy” rating on shares of BTG plc in a research note on Wednesday, July 16th. They now have a GBX 670 ($11.09) price target on the stock. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of GBX 553.57 ($9.16).
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with Analyst Ratings Network's FREE daily email newsletter.